Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.058 | 0.7 |